APPLICATION
ANDA087887
TYPE
ANDA
ORIGINAL APPROVAL
1982-07-23
LATEST ACTION
1996-03-07
ROUTE
VAGINAL
DOSAGE FORM
CREAM
MARKETING STATUS
Discontinued
Products
TRYSULDiscontinued
TRIPLE SULFA (SULFABENZAMIDE 3.7%, SULFACETAMIDE 2.86%, SULFATHIAZOLE) 3.42% · CREAM · VAGINAL
Approval history
1996-03-07Manufacturing (CMC) · Supplement 15AP
1995-03-30Labeling · Supplement 13AP
1992-06-17Labeling · Supplement 12AP
1989-12-13Manufacturing (CMC) · Supplement 9AP
1989-12-13Manufacturing (CMC) · Supplement 10AP
1988-08-12Manufacturing (CMC) · Supplement 11AP
1988-02-18Manufacturing (CMC) · Supplement 7AP
1987-08-12Manufacturing (CMC) · Supplement 4AP
1987-08-12Manufacturing (CMC) · Supplement 5AP
1982-07-23OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.